Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18 Years and Older”

257 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 257 results

Not applicableNot Yet RecruitingNCT07451691
What this trial is testing

The Effect of the World Health Organisation-Based Intrapartum Care Model on Labour Pain, Comfort, Satisfaction and Postpartum Depression

Who this might be right for
18 Years and OlderTerm Pregnancy
Kahramanmaras Sutcu Imam University 108
Large-scale testing (Phase 3)Study completedNCT05572879
What this trial is testing

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Who this might be right for
COVID-19
EuBiologics Co.,Ltd 2,600
Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Large-scale testing (Phase 3)Ended earlyNCT05643573
What this trial is testing

Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Who this might be right for
Prevention of Stroke or Systemic EmbolismAtrial Fibrillation
Bayer 14,830
Testing effectiveness (Phase 2)Study completedNCT05373472
What this trial is testing

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
CanSino Biologics Inc. 150
Testing effectiveness (Phase 2)UnknownNCT05522829
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Not applicableUnknownNCT03074266
What this trial is testing

Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older

Who this might be right for
Blood Coagulation Test
Accriva Diagnostics 140
Large-scale testing (Phase 3)Study completedNCT03379727
What this trial is testing

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 301
Testing effectiveness (Phase 2)Study completedNCT01256398
What this trial is testing

Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT01285167
What this trial is testing

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 3,645
Not applicableStudy completedNCT04464291
What this trial is testing

An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years

Who this might be right for
Pneumonia, PneumococcalInvasive Pneumococcal DiseaseAcute Otitis Media
The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) 500
Large-scale testing (Phase 3)Study completedNCT03760146
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults

Who this might be right for
Pneumococcal Disease
Pfizer 3,902
Testing effectiveness (Phase 2)Looking for participantsNCT07379580
What this trial is testing

Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Who this might be right for
Mpox (Monkeypox)SmallpoxOrthopoxvirus Infection
BioNTech SE 310
Testing effectiveness (Phase 2)Study completedNCT00792623
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).

Who this might be right for
Varicella
GlaxoSmithKline 45
Not applicableStudy completedNCT01346046
What this trial is testing

Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2

Who this might be right for
Diabetes Mellitus, Non-Insulin Dependent
VeraLight, Inc. 264
Post-approval studies (Phase 4)Study completedNCT04911790
What this trial is testing

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 131,650
Testing effectiveness (Phase 2)Study completedNCT05525208
What this trial is testing

Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

Who this might be right for
COVID-19
PT Bio Farma 696
Testing effectiveness (Phase 2)Study completedNCT06015308
What this trial is testing

Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

Who this might be right for
Dermatitis Atopic
Sanofi 224
Testing effectiveness (Phase 2)Study completedNCT01457144
What this trial is testing

Study of Mantle Cell Lymphoma Treatment by RiBVD

Who this might be right for
Mantle Cell Lymphoma
French Innovative Leukemia Organisation 76
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Load More Results